Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Pulmonary Disease Physician in Berlin, MD
NPI: 1548227135Primary Practice Location
ATLANTIC GENERAL HOSPITAL
9733 Healthway Dr, Berlin, MD
Primary Employer
Option Care
optioncareltd.com
HQ Phone
Get M.D. Michael's Phone Numberphone_androidMobile
Get M.D. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
MD State Medical License
1994 - 2026
The Johns Hopkins University School of Medicine
hopkinsmedicine.org
Medical School
Until 1991
Johns Hopkins University
Fellowship • Pulmonary Disease and Critical Care Medicine
1996 - 1999
Residency • Internal Medicine
1991 - 1994
Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres.
Authors: S.J. Doe, A. McSorley, B. Isalska, A.M. Kearns, R. Bright-Thomas, A.L. Brennan, A.K. Webb, Andrew Jones
Publication Date: 2010-03
Persistent Infection with Small Colony Variant Strains of Staphylococcus aureus in Patients with Cystic Fibrosis
Authors: Barbara C. Kahl, Mathias Herrmann, Anne Schulze Everding, H. G. Koch, Karsten Becker, Erik Harms, Richard A. Proctor, Georg Peters
Publication Date: 1998-04
The evidence for long-term benefits of restoration of CFTR function continues to grow.
Authors: Michael P. Boyle
Publication Date: 2015-10
Lead Sponsor: Johns Hopkins University
Collaborators: Case Western Reserve University, Cystic Fibrosis Foundation
Intervention / Treatment: DRUG: Rifampin, DRUG: Doxycycline, DRUG: Trimethoprim/Sulfamethoxazole (TMP/SMX), DRUG: Inhaled Vancomycin, DRUG: Placebo (Sterile Water), DRUG: Mupirocin Intranasal Creme, DRUG: 4% chlorhexidine gluconate liquid skin cleanser
